758 related articles for article (PubMed ID: 15606411)
61. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
62. Small-sample performance of the robust score test and its modifications in generalized estimating equations.
Guo X; Pan W; Connett JE; Hannan PJ; French SA
Stat Med; 2005 Nov; 24(22):3479-95. PubMed ID: 15977302
[TBL] [Abstract][Full Text] [Related]
63. Sample size for two-stage studies with maintenance therapy.
Feng W; Wahed AS
Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
[TBL] [Abstract][Full Text] [Related]
64. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
Ogungbenro K; Aarons L
J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
[TBL] [Abstract][Full Text] [Related]
65. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic.
Liu W
Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710
[TBL] [Abstract][Full Text] [Related]
66. Adaptive design: estimation and inference with censored data in a semiparametric model.
Shen Y; Cheng Y
Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
[TBL] [Abstract][Full Text] [Related]
67. Confidence intervals based on some weighting functions for the difference of two binomial proportions.
Maruo K; Kawai N
Stat Med; 2014 Jun; 33(13):2288-96. PubMed ID: 24644149
[TBL] [Abstract][Full Text] [Related]
68. Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer.
O'Quigley J
Biometrics; 1992 Sep; 48(3):853-62. PubMed ID: 1420845
[TBL] [Abstract][Full Text] [Related]
69. Exact one-sided confidence limits for the difference between two correlated proportions.
Lloyd CJ; Moldovan MV
Stat Med; 2007 Aug; 26(18):3369-84. PubMed ID: 17315269
[TBL] [Abstract][Full Text] [Related]
70. A note on effective sample size for constructing confidence intervals for the difference of two proportions.
Liu GF
Pharm Stat; 2012; 11(2):163-9. PubMed ID: 22337507
[TBL] [Abstract][Full Text] [Related]
71. Inference on treatment effects for targeted clinical trials under enrichment design.
Liu JP; Lin JR; Chow SC
Pharm Stat; 2009; 8(4):356-70. PubMed ID: 19180519
[TBL] [Abstract][Full Text] [Related]
72. On sample size and inference for two-stage adaptive designs.
Liu Q; Chi GY
Biometrics; 2001 Mar; 57(1):172-7. PubMed ID: 11252594
[TBL] [Abstract][Full Text] [Related]
73. Sample size for testing and estimating the difference between two paired and unpaired proportions: a 'two-step' procedure combining power and the probability of obtaining a precise estimate.
Cesana BM
Stat Med; 2004 Aug; 23(15):2359-73. PubMed ID: 15273953
[TBL] [Abstract][Full Text] [Related]
74. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
75. Exact and approximate unconditional confidence intervals for proportion difference in the presence of incomplete data.
Tang ML; Ling MH; Tian GL
Stat Med; 2009 Feb; 28(4):625-41. PubMed ID: 19035467
[TBL] [Abstract][Full Text] [Related]
76. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
Lord D
Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
[TBL] [Abstract][Full Text] [Related]
77. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
78. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
Strickland PA; Lu SE
Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
[TBL] [Abstract][Full Text] [Related]
79. Supplementary analysis of probabilities at the termination of a group sequential phase II trial.
Liu A; Wu C; Yu KF; Gehan E
Stat Med; 2005 Apr; 24(7):1009-27. PubMed ID: 15565737
[TBL] [Abstract][Full Text] [Related]
80. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
